Download the slides from Eric Siemers, MD of Eli Lilly and Company recent presentation, Can Biomarkers Enhance Success Rates in Future AD Clinical Trials from the Quintiles Symposium, Navigating Future Challenges in Alzheimer's Disease Trials at ICAD 2010.